HO2 — DR Horton Income Statement
0.000.00%
Last trade - 00:00Consumer CyclicalsAdventurousLarge CapNeutral
- €34.00bn
- €37.10bn
- $33.48bn
- 54
- 59
- 99
- 84
Annual income statement for DR Horton, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2018 September 30th | 2019 September 30th | 2020 September 30th | 2021 September 30th | 2022 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16,068 | 17,593 | 20,311 | 27,774 | 33,480 |
| Cost of Revenue | |||||
| Gross Profit | 3,720 | 3,925 | 4,961 | 7,900 | 10,565 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 14,008 | 15,468 | 17,328 | 22,418 | 25,850 |
| Operating Profit | 2,060 | 2,125 | 2,983 | 5,356 | 7,630 |
| Net Income Before Taxes | 2,060 | 2,125 | 2,983 | 5,356 | 7,630 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 1,571 | 1,619 | 2,381 | 4,191 | 5,896 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 1,460 | 1,619 | 2,374 | 4,176 | 5,858 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 1,460 | 1,619 | 2,374 | 4,176 | 5,858 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 4.18 | 4.29 | 6.34 | 11.5 | 16.7 |
| Dividends per Share |